SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
Telegram Restored on Apple App Store After Temporary Removal 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
WATERBURY, Conn., March 28, 2018 -- Northeast Scientific, Inc. (NES), known for its advanced medical device reprocessing capability, received another 510K clearance from the FDA on 27 March, this time for the RF Stylet manufactured by Covidien, a division of Medtronic.
This FDA clearance gives NES the green light to reprocess and market the stylet. The device, originally manufactured by VNUS, is used in vessel and tissue coagulation, including treatment of incompetent (i.e., refluxing) perforator and tributary veins.
“The proprietary systems we have built for the ClosureFast RF Ablation Catheter are just a natural fit for the RF Stylet,” said NES CEO, Craig Allmendinger.
NES has sold over 250,000 ClosureFast RF Ablation devices since 2012 with superior safety results.
“The Stylet will get the same rigorous treatment as ClosureFast,” Allmendinger said. “The market has come to love the efficiency of our reprocessing service and they will get the same with this device.”
Reprocessing under an FDA 510K allows doctors to use a single-use device several times and reduce their costs. The NES focus on reprocessing more complex and costly devices provides even greater savings for end-users. Some NES customers save over $100,000 annually with just the Reprocessed ClosureFast RF Ablation catheter alone.
Reprocessing also prolongs the useful life of millions of devices, reducing the tonnage that finds its way to landfills or to the incinerator each year.
For more information, visit www.smarthealth-care.com.
About Northeast Scientific
Northeast Scientific, Inc. (NES), in Waterbury, Connecticut, is registered with the U.S. Food and Drug Administration as both a reprocessor of single-use medical devices and a manufacturer. Founded in 2005, NES received its first 510(k) clearance in 2007, has added new products to its reprocessing suite and is developing multiple 510ks in the vascular space. NES is ISO 13485 2016 Certified.
Northeast Scientific Inc. Media Contact
Scott Allmendinger 203.756.2111
